PATENT CLAIM ANALYSIS

Application Number: 16014446
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["424", "145100"]

Abstract:
The invention relates to a multiple-variable dose method for treating a disorder in which TNFα activity is detrimental, comprising administering to a subject in need thereof a first induction dose of an anti-TNFα antibody which ranges from 161 to 320 mg such that a threshold level of TNFα inhibitor is achieved within an induction phase; and subsequently administering to the subject at least one treatment dose of the TNFα inhibitor within a treatment phase, such that treatment occurs

Claim (Index 15):
The method of  claim 13 , wherein the treatment dose is administered biweekly.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 94.0
- Lexical Diversity: 1.58824
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16014469', '15564677', '13433205', '14628068', '14229664']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6862799106040494
- 35 USC 102 Novelty (BERT): 0.5611475333430357
- Combined Prediction Score: 0.673766672877948
- Mean Citation Score: 369.772512
- Max Citation Score: 442.74567
- Similarity Product: 303.6214496220553

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test